27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Shares of Precision BioSciences (NASDAQ:DTIL) rose 8.2% in pre-market trading after the company reported Q1 results.
Quarterly Results
Earnings per share rose 73.87% year over year to ($0.52), which were in line with the estimate of ($0.52).
Revenue of $6,998,000 rose by 28.12% from the same period last year, which beat the estimate of $4,260,000.
Guidance
Earnings guidance hasn't been issued by the company for now.
Precision BioSciences hasn't issued any revenue guidance for the time being.
Technicals
Company's 52-week high was at $23.67
Company's 52-week low was at $4.60
Price action over last quarter: Up 20.18%
Company Description
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!